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Dr T. Bruce Ferguson (Greenville, NC). This nice analysis of
major patient risk factor observational processes and outcomes
compared between 2000 and 2009 (>1.4 million patients) is an ex-
cellent update. They did a nice job of handling different versions of
the STS database data in their trends over time analysis. The study
clearly documented continued improvement in CABG outcomes,
particularly in the CABG PCI era of the last decade.
I have 2 questions for the authors. The first is, you appropriately
attribute improvement to better perioperative management overall,
but 25% of the patients in 2009 had prior PCI and 32% had left
main disease, and the number of distal anastomoses increased
from 2000 to 2009. These are clearly more technically difficult op-
erations. Given your study and the recent JAMA report on the over-
all decline in CABG volumes during this same time frame,
although the number of CABG sites has increased, do you foresee
a reversal in this trend as sites perform fewer and fewer CABG pro-
cedures, and if so, what might be done about this at the local level?
The second question is that you discussed CABG versus PCI
outcomes in your article and the difference in the SYNTAX mor-
tality outcomes. If you substitute the SYNTAX PCI arm data with
the fractional flow reserve–guided PCI data from FFR versus An-
giography for Guiding PCI in Patients with Multivessel Coronary
Artery Disease (FAME), the mortality benefit from CABG disap-
pears. While this is being tested directly in the National Heart,
Lung, and Blood Institute ischemia trial, which is just getting un-
der way, what do you recommend as options to further improve
CABG outcomes in the future to keep up with our interventional
colleagues?
Dr ElBardissi. With regard to your first question, a number of
studies recently have shown that although there was a significant
decline in number of CABGs performed immediately after PCI
was adopted and certainly through the 1980s and 1990s, there
has certainly been a more recent decrease in the decline in
CABG volume. Furthermore, we believe that with studies like
these showing excellent outcomes after CABG, we continue to ex-
pect, at the very least, the decline in the number of CABGs to tem-
per even further.
Dr Ferguson. Sorry. My question was the decline in the im-
provement in outcomes from CABG, not the decline in the number
of CABGs that are done.
Dr ElBardissi. That is a very different question. It certainly is
possible that average institutional volumes will decline as a result
of the combination of decreasing global CABG volumes and an in-
crease in the number of hospitals performing CABG, and lower
volumes could reverse the trend toward improved outcomes. The
volume–outcome relationship for CABG is not as strong as for
some other cardiac operations. It should be noted that these data280 The Journal of Thoracic and Cardiovascular Surginclude only immediate postoperative outcomes, thus making it
hard to infer potential differences in long-term outcomes, includ-
ing long-term survival and revascularization.
I think your second question referred to CABG versus PCI out-
comes and recommending additional interventions or therapies
that would potentially improve the performance of CABG in rela-
tive to PCI. This study clearly illustrates we are performing CABG
on a very different cohort of patients and patients compared with
10 years ago.
It is essential that we continue to focus on reducing not only
mortality but also 2 keymorbidities: stroke and renal failure. There
remains room for improvement here.
Dr Paul Kurlansky (Miami, Fla). A very interesting study. It
parallels some work that was done by Dr Ferguson and colleagues
with regard to the STS database in the 1990s, who showed an in-
creasing risk and declining mortality for CABG surgery, and sim-
ilar findings have been shown in the New York State database over
time with increasing risk and declining mortality. I was wondering
if you would care to comment on the potential impact of large reg-
istries, which make us all aware of our results, on the actual out-
comes that we have been observing?
Dr ElBardissi. This is by far the largest cohort of patients we
have reviewed (1.4 million patients over the past decade), and
we have done a rigorous analysis to not only adjust for preopera-
tive risk but also ensure that the variables we are looking at are
consistent over time. I think all of us in this room recognize that
the STS database is one of the most valuable assets of the specialty
of cardiac surgery.
The major implication of this study is that we are in fact oper-
ating on amore complex cohort of patients and doing a better job at
getting them through the immediate postoperative phase with less
complications and particularly less mortality and less stroke than
they were not too long ago, 10 years ago.
The STS database was set up for quality improvement, and the
results of this study suggest that it has succeeded in that role. By
providing cardiac surgeons with regular reports that include risk-
adjusted outcomes for CABG and other cardiac operations along
with national and regional benchmarks, the STS database has cat-
alyzed improvement in both process and outcomes. The process of
measuring and reporting outcomes has been a powerful stimulus
for practice improvement.
Dr James Tatoulis (Melbourne, Australia). I noticed that less
than 5% of patients were having bilateral ITAs despite the cohort
having a median age of 65 years. Could you comment on how this
has changed in the last 10 years, particularly now the population is
aging and patients live longer, and whether you can use this type of
study to perhaps stimulate some progress in that area?
Dr ElBardissi. Bilateral ITAs at the beginning of our study
were 3.5%, and it just increased slightly to 4.1% at the end of
the study; an increase in the use of bilateral ITAs but certainly
not a large increase. Certainly increased focus on the rate of bilat-
eral ITA grafting might lead to increased adoption of this strategy.
Dr Ottavio Alfieri (Milan, Italy). What is your personal inter-
pretation of the improvements? If you could identify just a single
factor affecting this improvement, what do you think it is?
Dr ElBardissi. We have seen improvements on many fronts.
We have seen improvements on process-oriented fronts, surgical
decision-making fronts, such as use of the ITA, and then weery c February 2012
ElBardissi et al Acquired Cardiovascular Diseasehave also seen improvements on the outcome fronts, mortality,
stroke rate, and so forth. The process-orientated fronts and surgical
decision-making fronts tend to reflect, again, the rigorous clinical
studies that are ongoing in the field of cardiac surgery that dictate
to us as cardiac surgeons what the optimal revascularization con-
figuration and strategies are going forward in any particular group
of patients.
The changes in outcomes we have seen, again, adjusting for
patient risk and still seeing a significant decline in mortality
and stroke rate, reflect a number of things. Number one, theyThe Journal of Thoracic and Careflect more optimal medical management when patients come
into surgery. Something that shouldn’t be lost is that this is
not just better care being received in the operating room, this
is probably better perioperative surgical care, preoperative, oper-
ative, and intensive care unit level care and floor level care. So I
think there are a number of things are going on here. It is diffi-
cult to know from our study exactly what is contributing to the
improved outcomes we have seen over the past decade, but cer-
tainly better intraoperative decision-making and better perioper-
ative surgical care.rdiovascular Surgery c Volume 143, Number 2 281
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